Roche’s Gazyva Gets FDA Approval for Lupus Nephritis

By Billy Gray

  Roche said the U.S Food and Drug Administration approved its Gazyva drug for the treatment of adults receiving standard therapy for a form of lupus that targets the kidneys. 

  The Swiss pharma group said Monday that the...